European Commission revised Investor Arbitration proposal still shows bias and lack of transparency

Brussels, 12 November 2015. Public health groups, including EPHA, EHN and EASL [1] consider that the proposed changes to investor arbitration in TTIP are insufficient to stop companies attacking governments on public health laws, such as those for plain tobacco packaging or transparency of clinical trials.